Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bal Pharma Ltd.
Swot
Bal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bal Pharma Ltd. has 8 Strengths, 7 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(7)
Opportunity
(1)
Threats
(0)
Others
(6)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with reducing Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Companies with growing costs YoY for long term projects
Degrowth in Revenue and Profit
Declining Net Cash Flow : Companies not able to generate net cash
Fall in Quarterly Revenue and Net Profit (YoY)
Increasing Trend in Non-Core Income
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
FII / FPI or Institutions increasing their shareholding
Rising Delivery Percentage Compared to Prev Day
Bullish or Bearish Candlestick Strength - Indices
Inverted Hammer (Bullish Reversal)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
